2022版WHO神经内分泌肿瘤分类解读  

Interpretation on the update of 2022 WHO classification of neuroendocrine tumors

作　　者：毛歆歆[1] 陈杰[1] Mao Xinxin;Chen Jie(Department of Pathology,Peking Union Medical College Hospital,Chinese Academy of Medical Science,Peking Union Medical College,Beijing 100730,China)

机构地区：[1]中国医学科学院,北京协和医学院,北京协和医院病理科,北京100730

出　　处：《中华病理学杂志》2024年第7期655-659,共5页Chinese Journal of Pathology

基　　金：中央高水平医院临床科研业务费(2022-PUMCH-A-027)。

摘　　要：2022年出版的第5版WHO内分泌与神经内分泌肿瘤蓝皮书,其中关于神经内分泌肿瘤分类有一定的改变,我们就该部分的主要改变做简要的总结和概括。主要归纳为命名改变,神经内分泌肿瘤分化、分级定义及解剖部位相关肿瘤分级系统,不同部位神经内分泌肿瘤形态特征,辅助诊断及预后/治疗标志物,神经内分泌肿瘤鉴别诊断及诊断难点。The 5th edition of the WHO Endocrine and Neuroendocrine Oncology Blue Book,released in 2022,contained some changes in the classification of neuroendocrine tumors.A brief summary of the main changes has been provided in this section.Mainly summarized as changes in naming,differentiation and classification of neuroendocrine tumors,and tumor grading systems related to anatomical locations,morphological characteristics of neuroendocrine tumors in different locations,auxiliary diagnostic and prognostic/therapeutic markers,differential diagnosis and diagnostic difficulties of neuroendocrine tumors.

关 键 词：国际疾病分类法 病理学 神经内分泌瘤 

分 类 号：R739.4[医药卫生—肿瘤]